DIAGNOSIS CODES FOR COVID-19 ANTIBODY TESTING Report code Z01. 84, “Encounter for antibody response examination,” if the antibody test is neither to confirm a current COVID-19 infection nor for follow-up of a known infection. For a current COVID-19 infection, report U07. 1 and codes for any manifestations.
To accurately assign the ICD-10 code D89. 9, disorder involving the immune mechanism unspecified, or D84. 9, immunodeficiency unspecified, the patient's immunocompromised state should not be attributed to a chronic condition or a prescribed medication therapy.
ICD-10 code D89. 9 for Disorder involving the immune mechanism, unspecified is a medical classification as listed by WHO under the range - Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism .
The patient's primary diagnostic code is the most important. Assuming the patient's primary diagnostic code is Z76. 89, look in the list below to see which MDC's "Assignment of Diagnosis Codes" is first.
Treating a patient who is immunocompromised poses more risks and challenges; therefore, it is important to identify a patient with this status. Code D84. 821, Immunodeficiency due to drugs, was created for immunodeficiency due to medications that interfere with the immune system.
People with immunodeficiency or autoimmune disease are considered immunocompromised, but other factors can also cause someone to be immunocompromised, such as cancer, cancer treatments, metabolic disorders or advanced age, according to The University of Texas MD Anderson Cancer Center.
9: Systemic involvement of connective tissue, unspecified.
A condition that affects the immune system. The immune system is made up of cells, tissues, and organs that help the body fight infections and other diseases. There are many different types of immune system disorders, including immunodeficiency disease, autoimmune disorders, and allergic disorders.
Undifferentiated connective tissue disease (UCTD) is a term suggested by LeRoy 30 years ago to denote autoimmune disease that does not meet criteria for established illnesses such as systemic lupus erythematosus, scleroderma, dermatomyositis, Sjogren's syndrome, vasculitis, or rheumatoid arthritis.
ICD-10 code Z51. 81 for Encounter for therapeutic drug level monitoring is a medical classification as listed by WHO under the range - Factors influencing health status and contact with health services .
ICD-Code I10 is a billable ICD-10 code used for healthcare diagnosis reimbursement of Essential (Primary) Hypertension.
ICD-10-PCS GZ3ZZZZ is a specific/billable code that can be used to indicate a procedure.